US 7105561
Use of etodolac for the treatment of prostate cancer
granted A61KA61K31/198A61K31/407
Quick answer
US patent 7105561 (Use of etodolac for the treatment of prostate cancer) held by The Regents of the University of California expires Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Sep 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K31/198, A61K31/407, A61K45/06